Bristol-Myers to buy Celgene in a $74 billion deal; Celgene shares surge By: CNBC.com News January 03, 2019 at 07:03 AM EST Bristol-Myers on Thursday announced plans to buy Celgene in a deal the company valued at $74 billion. Read More >> Related Stocks: Bristol-Myers Squibb Celgene Corp